Aspiriant, LLC Merck & Co., Inc. Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aspiriant, LLC holds 15,377 shares of MRK stock, worth $1.53 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

15,377

Previous 15,912 3.36%

Holding current value

$1.53 Million

Previous $1.97 Million 11.33%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$111.15 - $128.97 $59,465 - $68,998	-535 Reduced 3.36%	15,377 $1.75 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $404,702 - $434,646	-3,269 Reduced 17.04%	15,912 $1.97 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $85,496 - $99,622	755 Added 4.1%	19,181 $2.53 Million
Q4 2023 Jan 26, 2024	BUY	$100.18 - $109.02 $16,128 - $17,552	161 Added 0.88%	18,426 $2.01 Million
Q3 2023 Oct 17, 2023	BUY	$102.95 - $114.33 $142,071 - $157,775	1,380 Added 8.17%	18,265 $1.88 Million
Q2 2023 Jul 19, 2023	SELL	$108.61 - $118.38 $10,317 - $11,246	-95 Reduced 0.56%	16,885 $1.95 Million
Q1 2023 Apr 27, 2023	BUY	$102.94 - $114.86 $18,529 - $20,674	180 Added 1.07%	16,980 $1.81 Million
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $16,963 - $21,749	-194 Reduced 1.14%	16,800 $0
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $59,255 - $66,566	701 Added 4.3%	16,994 $1.46 Million
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $38,071 - $43,155	-456 Reduced 2.72%	16,293 $1.48 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $23,890 - $26,780	-325 Reduced 1.9%	16,749 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $176,796 - $221,460	2,446 Added 16.72%	17,074 $1.31 Million
Q3 2021 Oct 27, 2021	SELL	$71.68 - $78.83 $12,974 - $14,268	-181 Reduced 1.22%	14,628 $1.1 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $18,843 - $20,842	268 Added 1.84%	14,809 $1.15 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $130,145 - $153,297	1,890 Added 14.94%	14,541 $1.12 Million
Q4 2020 Feb 01, 2021	SELL	$71.77 - $79.65 $2.13 Million - $2.36 Million	-29,662 Reduced 70.1%	12,651 $1.03 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $2.16 Million - $2.45 Million	29,571 Added 232.08%	42,313 $3.51 Million
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $96,968 - $110,339	-1,377 Reduced 9.75%	12,742 $983,000
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $59,495 - $82,462	939 Added 7.12%	14,119 $1.08 Million
Q4 2019 Jan 27, 2020	SELL	$77.58 - $87.54 $35,376 - $39,918	-456 Reduced 3.34%	13,180 $1.2 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $11,488 - $12,522	-151 Reduced 1.1%	13,636 $1.15 Million
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $61,948 - $72,370	-887 Reduced 6.04%	13,787 $1.16 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $339,272 - $386,959	-4,876 Reduced 24.94%	14,674 $1.22 Million
Q4 2018 Feb 04, 2019	SELL	$65.24 - $75.71 $69,611 - $80,782	-1,067 Reduced 5.18%	19,550 $1.49 Million
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $96,976 - $114,039	-1,681 Reduced 7.54%	20,617 $1.46 Million
Q2 2018 Aug 07, 2018	BUY	$50.83 - $59.72 $56,014 - $65,811	1,102 Added 5.2%	22,298 $1.35 Million
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $1.08 Million - $1.26 Million	21,196 New	21,196 $1.16 Million
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $1.05 Million - $1.25 Million	-20,341 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $1.19 Million - $1.28 Million	20,341	20,341 $1.3 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account